Virtual Patient-Specific 3-Dimensional Specimen Maps for Adjuvant Radiation Therapy Planning in Mucosal Head and Neck Squamous Cell Carcinoma

Whitney Jin, Michael C Topf, Marina Aweeda, Kavita Prasad, Olivia Prosak, Sindhura Sridhar, Zachary Kohutek, Sean All, DW Nathan Kim, Anthony Cmelak, Ryan Whitaker, Alexander Langerman, Kyle Mannion, Melanie Hicks, Sarah Rohde, Robert Sinard, Eben Rosenthal, Natalie A Lockney · 2026

Read Virtual Patient-Specific 3-Dimensional Specimen Maps for Adjuvant Radiation Therapy Planning in Mucosal Head and Neck Squamous Cell Carcinoma by Whitney Jin, Michael C Topf, Marina Aweeda, Kavita Prasad, Olivia Prosak, Sindhura Sridhar, Zachary Kohutek, Sean All, DW Nathan Kim, Anthony Cmelak, Ryan Whitaker, Alexander Langerman, Kyle Mannion, Melanie Hicks, Sarah Rohde, Robert Sinard, Eben Rosenthal, Natalie A Lockney (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263730.txt.

Introduction

Whitney Jin and colleagues give radiation oncologists a three-dimensional map of the tumor they just removed. After head and neck surgery, shifted anatomy makes aiming adjuvant radiation guesswork. Their 2026 feasibility study scans thirteen surgical specimens and annotates the pathology onto virtual models.

Maps joined the planning workflow and a multidisciplinary review for each patient. Target volumes changed in three cases for the main zone and three for the boost zone, expanding or shrinking with better margin knowledge. Doses to nearby organs shifted only slightly. Oncologists' confidence in their volumes and margin localization jumped significantly on surveys. Precision planning gained a shared visual language.

Catalog record

CREATORWhitney Jin, Michael C Topf, Marina Aweeda, Kavita Prasad, Olivia Prosak, Sindhura Sridhar, Zachary Kohutek, Sean All, DW Nathan Kim, Anthony Cmelak, Ryan Whitaker, Alexander Langerman, Kyle Mannion, Melanie Hicks, Sarah Rohde, Robert Sinard, Eben Rosenthal, Natalie A Lockney
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13263730

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Virtual Patient-Specific 3-Dimensional Specimen Maps for Adjuvant Radiation Therapy Planning in Mucosal Head and Neck Squamous Cell Carcinoma Authors: Whitney Jin, Michael C Topf, Marina Aweeda, Kavita Prasad, Olivia Prosak, Sindhura Sridhar, Zachary Kohutek, Sean All, DW Nathan Kim, Anthony Cmelak, Ryan Whitaker, Alexander Langerman, Kyle Mannion, Melanie Hicks, Sarah Rohde, Robert Sinard, Eben Rosenthal, Natalie A Lockney Published: 2026 ABSTRACT AbstractPurposeAdjuvant radiation therapy planning for mucosal head and neck squamous cell carcinoma is challenging due to postoperative anatomic changes, contributing to variability in clinical target volume (CTV) delineation and risk of geographic miss or unnecessary dose expansion. Patient-specific 3-dimensional (3D) specimen maps may offer a novel approach to improve the localization of high-risk margins and facilitate multidisciplinary communication.Methods and MaterialsIn this prospective, noninterventional feasibility study, 3D scanning and virtual pathologic mapping of surgical specimens were performed as part of routine pathologic processing. Annotated 3D maps were integrated into the radiation therapy planning workflow and reviewed by the multidisciplinary team. Two adjuvant radiation therapy plans were prepared: 1 per standard of care and 1 with a 3D specimen map added. Changes in CTV primary or CTV boost delineation, dosimetric parameters for organs at risk, and clinician-reported confidence were assessed.ResultsThirteen patients were treated by 5 radiation oncologists. Changes in CTV primary and CTV boost delineation occurred in 3 cases each. 3D specimen mapping enabled focal expansion or reduction of boost volumes, reflecting improved localization of high-risk surgical margins. Small dosimetric changes were observed for organs at risk, but none exceeded clinically significant thresholds. Radiation oncologists reported increased confidence in treatment volumes (mean score increased from 64.5 to 84.9; P = .02) and improved ability to localize positive margins (mean score increased from 51.6 to 75.4; P = .02).ConclusionsIntegration of patient-specific 3D specimen maps into adjuvant radiation therapy planning for head and neck squamous cell carcinoma is feasible and can meaningfully influence target delineation, particularly for boost volumes. This strategy improves margin localization, multidisciplinary communication, and clinician confidence, with the potential to optimize oncologic coverage. Introduction According to the National Comprehensive Cancer Network guidelines, adjuvant radiation with or without concurrent chemotherapy is indicated following surgical resection of mucosal head and neck squamous cell carcinoma (SCC) when intermediate- and high-risk features, such as advanced pathologic tumor stage, close or positive margins, positive lymph nodes, extranodal extension (ENE), lymphovascular invasion (LVI), and/or perineural invasion (PNI), are present.1,2 The clinical target volume (CTV) for the primary site (CTVp) is typically treated to 60 Gy and includes the operative bed, with a margin to account for microscopic disease. In cases of positive margins or ENE, the radiation oncologist may consider a localized boost up to 66 Gy to the anatomic area of concern.3,4 Accurate identification of the boost volume (CTVb) is critical, as uncertainty in margin location may affect both target coverage and dose to adjacent organs at risk (OARs), which can contribute to suboptimal locoregional control and increased late-term side effects. Adjuvant radiation treatment planning for mucosal head and neck cancer is challenging due to significant postsurgical anatomic changes, including the loss of native tissue planes, postoperative inflammation, fluid collection, and surgical manipulation or reconstruction.5,6 The current standard of care involves a multidisciplinary approach, including review of preoperative imaging, operative reports, and expert consensus, to ensure precise targeting and minimize toxicity. However, these methods have notable limitations that can impact accuracy and consistency. Written operative reports vary in quality and may lack precise anatomic details or be misinterpreted. This makes it difficult to reconstruct the exact location of close/positive margins or the extent of resection, which can increase the risk of geographic miss.7,8 Preoperative computed tomography (CT), magnetic resonance imaging, and positron emission tomography/CT will not reflect postsurgical anatomic distortion, and errors in imaging acquisition or fusion can affect the entire treatment plan. Moreover, there is substantial variability in treatment decisions among radiation oncologists, particularly in the absence of consensus guidelines for target volume delineation in the adjuvant setting. While consensus guidelines exist for primary tumor CTV delineation in the definitive setting, no standardized recommendations are currently available in the postoperative context.6,7,9 Prior studies have shown that ex vivo optical 3-dimensional (3D) scanning and virtual 3D specimen maps can improve communication among surgeons, medical oncologists, radiation oncologists, and pathologists in multidisciplinary care.10, 11, 12, 13 Unlike preoperative imaging, which defines gross tumor extent prior to resection, 3D specimen mapping is designed to spatially contextualize microscopic margin status after resection within the distorted postoperative anatomy. However, the use of 3D specimen maps to specifically improve the delineation of adjuvant radiation treatment volumes has not been evaluated. This study evaluates whether incorporating 3D tumor specimen maps into multidisciplinary care alters CTVp and CTVb delineation and directly influences radiation oncologist decision-making. Methods and Materials Study population Following approval from the University-affiliated institutional review board (number 221597), patients with biopsy-proven head and neck cancer who underwent primary resection at any mucosal head and neck anatomic subsite (oral cavity, oropharynx, hypopharynx, or larynx) scheduled to receive standard-of-care adjuvant radiation at the institutional medical center were considered for accrual in the study. Cutaneous malignancies were excluded. Patients were included only if all study components (Fig. 1) were completed. Patients and treating radiation oncologists provided consent prior to participation. All mucosal histopathology types were included; patients with cutaneous malignancies were excluded. Patient characteristics were extracted from the electronic medical record. Chart review was performed to assess patient age, tumor histology, pathologic tumor and nodal stage, anatomic subsite, surgical procedure, and pathologic features (PNI, LVI, ENE, and final margin status). All staging was reported according to the eighth edition of the American Joint Committee on Cancer staging system. Study protocol. Each patient had 2 plans drawn (1 standard arm and 1 investigational arm). Only the standard-of-care plan was used to treat the patient. Abbreviations: 3D = 3-dimensional; CTV, clinical tumor volume; CTVb, clinical tumor volume boost; CTVp, clinical tumor volume primary; CTVp3D = clinical tumor volume primary with 3D model; CTVb3D = clinical tumor volume boost with 3D model; IRB = institutional review board. 3D Scanning and Visual Pathology Report Protocol As previously described, resected oncologic specimens were scanned by research personnel prior to standard-of-care pathologic processing. Specimens were transported from the operating room to the pathology laboratory, rinsed with water, and patted dry to reduce glare or reflective surfaces.11,12 All specimens included in this study were submitted en bloc to reflect native anatomic orientation prior to scanning. Piecemeal resections were excluded from this study. A commercially available structured-light 3D scanner (EinScan SP, Shining 3D) and its accompanying software (EXScan, Shining 3D) were set up on a mobile cart immediately outside the operating room and used to capture the 3D topography of the ex vivo specimen. The specimen was placed on a turntable in the enclosed cart to reduce light exposure, and the top face of the specimen was scanned 360 degrees. The specimen was then manually flipped to scan the second face. The 2-point cloud matrices were manually aligned using 3-point cross-registration, yielding a virtual 3D model of the surgical specimen. The 3D scan was exported as a watertight, high-quality 3D mesh model and saved as 3MF and OBJ files. The entire process took an average of 8 minutes, and the specimen

Read the complete text